Shanghai RAAS Blood Products Co Ltd Class A (002252) — Financial Flexibility Index

Latest as of December 2025: -0.13x

Shanghai RAAS Blood Products Co Ltd Class A (002252) has a Financial Flexibility Index of -0.13x as of December 2025. Free cash flow of CN¥-672.37 Million (operating CF CN¥-843.75 Million minus capex CN¥171.38 Million) represents 0% of total liabilities (CN¥5.33 Billion). Check 002252 total capital reinvestment ratio to assess the company's total reinvestment commitment from operating cash flow.

Financial Flexibility Index

-0.13x
Free Cash Flow / Total Liabilities

Free Cash Flow

CN¥-672.37 Million
Operating CF − Capex

Total Liabilities

CN¥5.33 Billion
CNY

Capital Expenditures

CN¥171.38 Million
CNY

Shanghai RAAS Blood Products Co Ltd Class A Financial Flexibility Index (2005–2025)

Historical Financial Flexibility Index trend for Shanghai RAAS Blood Products Co Ltd Class A across 21 annual periods. For the full cash flow conversion analysis, see Shanghai RAAS Blood Products Co Ltd Clas operating cash flow efficiency.

Annual Financial Flexibility Index for Shanghai RAAS Blood Products Co Ltd Class A (2005–2025)

Year-by-year free cash flow to debt coverage for Shanghai RAAS Blood Products Co Ltd Class A. Explore 002252 debt coverage from operations to assess how comfortably operating cash covers total debt obligations.

Year Flexibility Index Free Cash Flow (CNY) Operating CF Total Liabilities YoY Change
2025 0.05x CN¥274.12 Million CN¥-104.89 Million CN¥5.34 Billion ▲ +215.9%
2024 -0.04x CN¥-74.91 Million CN¥-482.06 Million CN¥1.69 Billion ▼ -103.7%
2023 1.20x CN¥2.73 Billion CN¥2.28 Billion CN¥2.28 Billion ▲ +0.9%
2022 1.19x CN¥1.95 Billion CN¥1.73 Billion CN¥1.64 Billion ▲ +5.5%
2021 1.12x CN¥1.50 Billion CN¥1.29 Billion CN¥1.33 Billion ▼ -71.2%
2020 3.91x CN¥1.42 Billion CN¥1.17 Billion CN¥363.74 Million ▲ +37.6%
2019 2.84x CN¥1.03 Billion CN¥872.69 Million CN¥361.95 Million ▲ +236.1%
2018 0.84x CN¥419.44 Million CN¥262.50 Million CN¥496.56 Million ▲ +291.1%
2017 0.22x CN¥426.60 Million CN¥268.76 Million CN¥1.98 Billion ▼ -58.9%
2016 0.53x CN¥785.71 Million CN¥638.22 Million CN¥1.50 Billion ▼ -51.2%
2015 1.08x CN¥907.81 Million CN¥762.42 Million CN¥843.64 Million ▲ +53.0%
2014 0.70x CN¥531.02 Million CN¥465.96 Million CN¥755.16 Million ▲ +741.2%
2013 0.08x CN¥39.57 Million CN¥-90.11 Million CN¥473.37 Million ▼ -96.2%
2012 2.19x CN¥413.16 Million CN¥263.46 Million CN¥188.79 Million ▼ -49.3%
2011 4.31x CN¥354.82 Million CN¥178.03 Million CN¥82.26 Million ▲ +47.7%
2010 2.92x CN¥289.42 Million CN¥200.21 Million CN¥99.12 Million ▲ +2.1%
2009 2.86x CN¥177.01 Million CN¥116.01 Million CN¥61.88 Million ▲ +59.7%
2008 1.79x CN¥136.87 Million CN¥107.64 Million CN¥76.42 Million ▲ +22.2%
2007 1.47x CN¥200.17 Million CN¥175.71 Million CN¥136.53 Million ▲ +276.0%
2006 0.39x CN¥65.67 Million CN¥53.58 Million CN¥168.39 Million ▼ -47.5%
2005 0.74x CN¥75.71 Million CN¥54.02 Million CN¥101.93 Million —
Financial Flexibility Index = (Operating CF − Capex) / Total Liabilities = Free Cash Flow / Total Liabilities